Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank Disease ID
1 Calcium signaling pathway 💬
 [1] FGFR2 💬 Infigratinib 💬 Infigratinib [1] 276 💬
2 Calcium signaling pathway 💬
 [1] FGFR2 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
3 Calcium signaling pathway 💬
 [1] FGFR2 💬 Palifermin 💬 Palifermin [5] 13, 36, 38, 39, 65 💬
4 Central carbon metabolism in cancer 💬
 [1] FGFR2 💬 Infigratinib 💬 Infigratinib [1] 276 💬
5 Central carbon metabolism in cancer 💬
 [1] FGFR2 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
6 Central carbon metabolism in cancer 💬
 [1] FGFR2 💬 Palifermin 💬 Palifermin [5] 13, 36, 38, 39, 65 💬
7 EGFR tyrosine kinase inhibitor resistance 💬
 [1] FGFR2 💬 Infigratinib 💬 Infigratinib [1] 276 💬
8 EGFR tyrosine kinase inhibitor resistance 💬
 [1] FGFR2 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
9 EGFR tyrosine kinase inhibitor resistance 💬
 [1] FGFR2 💬 Palifermin 💬 Palifermin [5] 13, 36, 38, 39, 65 💬
10 Endocytosis 💬
 [1] FGFR2 💬 Infigratinib 💬 Infigratinib [1] 276 💬
11 Endocytosis 💬
 [1] FGFR2 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
12 Endocytosis 💬
 [1] FGFR2 💬 Palifermin 💬 Palifermin [5] 13, 36, 38, 39, 65 💬
13 Gastric cancer 💬
 [1] FGFR2 💬 Infigratinib 💬 Infigratinib [1] 276 💬
14 Gastric cancer 💬
 [1] FGFR2 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
15 Gastric cancer 💬
 [1] FGFR2 💬 Palifermin 💬 Palifermin [5] 13, 36, 38, 39, 65 💬
16 MAPK signaling pathway 💬
 [1] FGFR2 💬 Infigratinib 💬 Infigratinib [1] 276 💬
17 MAPK signaling pathway 💬
 [1] FGFR2 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
18 MAPK signaling pathway 💬
 [1] FGFR2 💬 Palifermin 💬 Palifermin [5] 13, 36, 38, 39, 65 💬
19 Pathways in cancer 💬
 [1] FGFR2 💬 Infigratinib 💬 Infigratinib [1] 276 💬
20 Pathways in cancer 💬
 [1] FGFR2 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
21 Pathways in cancer 💬
 [1] FGFR2 💬 Palifermin 💬 Palifermin [5] 13, 36, 38, 39, 65 💬
22 PI3K-Akt signaling pathway 💬
 [1] FGFR2 💬 Infigratinib 💬 Infigratinib [1] 276 💬
23 PI3K-Akt signaling pathway 💬
 [1] FGFR2 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
24 PI3K-Akt signaling pathway 💬
 [1] FGFR2 💬 Palifermin 💬 Palifermin [5] 13, 36, 38, 39, 65 💬
25 Prostate cancer 💬
 [1] FGFR2 💬 Infigratinib 💬 Infigratinib [1] 276 💬
26 Prostate cancer 💬
 [1] FGFR2 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
27 Prostate cancer 💬
 [1] FGFR2 💬 Palifermin 💬 Palifermin [5] 13, 36, 38, 39, 65 💬
28 Rap1 signaling pathway 💬
 [1] FGFR2 💬 Infigratinib 💬 Infigratinib [1] 276 💬
29 Rap1 signaling pathway 💬
 [1] FGFR2 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
30 Rap1 signaling pathway 💬
 [1] FGFR2 💬 Palifermin 💬 Palifermin [5] 13, 36, 38, 39, 65 💬
31 Ras signaling pathway 💬
 [1] FGFR2 💬 Infigratinib 💬 Infigratinib [1] 276 💬
32 Ras signaling pathway 💬
 [1] FGFR2 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
33 Ras signaling pathway 💬
 [1] FGFR2 💬 Palifermin 💬 Palifermin [5] 13, 36, 38, 39, 65 💬
34 Regulation of actin cytoskeleton 💬
 [1] FGFR2 💬 Infigratinib 💬 Infigratinib [1] 276 💬
35 Regulation of actin cytoskeleton 💬
 [1] FGFR2 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
36 Regulation of actin cytoskeleton 💬
 [1] FGFR2 💬 Palifermin 💬 Palifermin [5] 13, 36, 38, 39, 65 💬
37 Signaling pathways regulating pluripotency of stem cells 💬
 [1] FGFR2 💬 Infigratinib 💬 Infigratinib [1] 276 💬
38 Signaling pathways regulating pluripotency of stem cells 💬
 [1] FGFR2 💬 Nintedanib 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
39 Signaling pathways regulating pluripotency of stem cells 💬
 [1] FGFR2 💬 Palifermin 💬 Palifermin [5] 13, 36, 38, 39, 65 💬

Back to top